Stroffolini T, Curianó C M, Congiu M E, Occhionero M, Mastrantonio Gianfrilli P
Public Health. 1989 Jan;103(1):31-4. doi: 10.1016/s0033-3506(89)80099-x.
Meningococcal disease in Italy decreased 29% in 1987 from the previous year. The highest number of cases was seen in the 1-4 year-old age group (27%). The frequency in army recruits was 5/100,000, still higher than the 0.57/100,000 in the general population, but less than the 7/100,000 reported in the previous year. Sixty-three percent of the isolates belonged to serogroup C while serogroup B constituted 25%. The proportion of strains resistant to sulphonamides was 52.6%. Six strains were resistant to rifampin and none to minocyclin. No secondary cases occurred. These results are consistent with the trends reported in Italy in 1986. There were two findings of interest in 1987: the absence of secondary cases, attributable to the appropriate administration of chemoprophylaxis; and the decrease in military cases, reflecting the use of bivalent serogroup (A + C) meningococcal polysaccharide vaccine in all new military recruits since January 1987.
1987年,意大利的脑膜炎球菌病发病率较上一年下降了29%。病例数最多的是1至4岁年龄组(占27%)。新兵中的发病率为十万分之五,仍高于普通人群的十万分之0.57,但低于上一年报告的十万分之七。分离出的菌株中,63%属于C群,而B群占25%。对磺胺类药物耐药的菌株比例为52.6%。有6株对利福平耐药,无一株对米诺环素耐药。未出现二代病例。这些结果与1986年意大利报告的趋势一致。1987年有两个有趣的发现:由于适当进行了化学预防,未出现二代病例;军事人员病例数减少,这反映了自1987年1月以来对所有新兵使用了双价(A + C)群脑膜炎球菌多糖疫苗。